Breaking News Instant updates and real-time market news.

SRPT

Sarepta

$112.12

-9.97 (-8.17%)

, SLDB

Solid Biosciences

$8.86

-0.3397 (-3.69%)

09:11
05/14/19
05/14
09:11
05/14/19
09:11

Fly Intel: Pre-market Movers

HIGHER: Sarepta (SRPT), up 4% after competitor Solid Biosciences (SLDB) disclosed additional safety events with the first patient treated at the new high dose in its Phase 1/2 micro-dystrophin gene therapy study in Duchenne muscular dystrophy... Facebook (FB), up 1% after Reuters reported the company is moving toward an agreement with the government regarding its privacy policies and practices that would put the social media company under 20 years of oversight. The deal could potentially resolve an investigation on whether the company breached a similar 2011 consent pact... Tyson Foods (TSN), up 1% after Credit Suisse upgraded the stock to Outperform and Argus upgraded it to Buy... Athersys (ATHX), up 6% after announcing that its clinical program evaluating MultiStem cell therapy for the treatment of Acute Respiratory Distress Syndrome has received fast track designation from the FDA... TransEnterix (TRXC), up 2% after BTIG analyst Sean Lavin upgraded shares to Buy from Neutral with a $3 price target. UP AFTER EARNINGS: CyberArk (CYBR), up 6%... Allot Communications (ALLT), up 2%. DOWN AFTER EARNINGS: Ralph Lauren (RL), down 1%... Limoneira (LMNR), down 10%... Tencent Music (TME), down 8%. ALSO LOWER: Solid Biosciences, down 40% after disclosing that it reported a serious adverse event to the FDA related to the company's SGT-001 gene therapy trial.

SRPT

Sarepta

$112.12

-9.97 (-8.17%)

SLDB

Solid Biosciences

$8.86

-0.3397 (-3.69%)

FB

Facebook

$181.47

-6.97 (-3.70%)

TSN

Tyson Foods

$79.59

-0.24 (-0.30%)

ATHX

Athersys

$1.58

-0.065 (-3.95%)

TRXC

TransEnterix

$1.27

-0.02 (-1.55%)

CYBR

CyberArk

$121.06

-4.7 (-3.74%)

ALLT

Allot Communications

$7.28

-0.07 (-0.95%)

RL

Ralph Lauren

$118.28

-5.97 (-4.80%)

LMNR

Limoneira

$21.99

-1 (-4.35%)

TME

Tencent Music

$16.00

-0.585 (-3.53%)

  • 14

    May

  • 14

    May

  • 14

    May

  • 14

    May

  • 14

    May

  • 30

    May

  • 30

    May

  • 30

    May

  • 03

    Jun

  • 06

    Jun

  • 06

    Jun

  • 10

    Jun

  • 12

    Jun

  • 13

    Jun

  • 19

    Aug

  • 13

    Nov

SRPT Sarepta
$112.12

-9.97 (-8.17%)

05/09/19
BARD
05/09/19
NO CHANGE
BARD
Outperform
Baird names Sarepta a 'Fresh Pick' ahead of Pfizer data
Baird analyst Brian Skorney named Sarepta as a "Fresh Pick" ahead of the report of competitive data due in late June from Pfizer's (PFE) Duchenne muscular dystrophy program that he predicts will "fall flat." If that turns out to be the case, it should remove the most significant overhang on Sarepta shares, contends Skorney, who keeps an Outperform rating on Sarepta.
05/14/19
RBCM
05/14/19
NO CHANGE
Target $188
RBCM
Outperform
Sarepta gene therapy offers $3B in additional opportunity, says RBC Capital
RBC Capital analyst Brian Abrahams kept his Outperform rating and $188 price target on Sarepta, saying the company's "emerging leadership position" in gene therapy manufacturing capacity is becoming more evident after "several years of major investments." The analyst notes that his assessment suggests as much as $3B in additional revenue opportunity and sees "considerable appreciation potential" for Sarepta stock as all of its pipeline programs continue to progress.
05/14/19
05/14/19
DOWNGRADE
Target $6

Underperform
Solid Biosciences downgraded to Underperform at Credit Suisse
As previously reported, Credit Suisse analyst Martin Auster (SLDB) downgraded Solid Biosciences to Underperform from Neutral as he sees enrollment challenges and pressured timelines ahead. Earlier this year, Solid presented underwhelming initial microdystrophin data for the three patients at the low dose, necessitating dose escalation from 5E13 vg/kg to 2E14 vg/kg, he notes. With another treatment-related SAE, the analyst expects enrollment at this high dose may prove challenging, and notes that while improved efficacy at the higher dose could offset AE issues, promising initial data from Sarepta (SRPT) and positive commentary from Pfizer (PFE) on its Gene Tx program limit upside. Auster also lowered his price target on Solid's shares to $6 from $7.
05/14/19
GSCO
05/14/19
DOWNGRADE
Target $4
GSCO
Sell
Solid Biosciences downgraded to Sell from Neutral at Goldman Sachs
Goldman Sachs analyst Salveen Richter downgraded Solid Biosciences (SLDB) to Sell from Neutral after the company disclosed additional safety events with the first patient treated at the new high dose in the Phase 1/2 micro-dystrophin gene therapy study in Duchenne muscular dystrophy. Richter, who noted that he has previously expressed concern regarding a higher SGT-001 dose given safety events at the low dose, sees continued risk with the SGT-001 program as the trial continues to enroll, he tells investors. The analyst, who views SGT-001 as "suboptimal" versus competitor Sarepta's (SRPT) gene therapy, cut his price target on Solid shares to $4 from $5.
SLDB Solid Biosciences
$8.86

-0.3397 (-3.69%)

05/14/19
FBCO
05/14/19
DOWNGRADE
FBCO
Underperform
Solid Biosciences downgraded to Underperform from Neutral at Credit Suisse
05/14/19
CHDN
05/14/19
DOWNGRADE
CHDN
Neutral
Solid Biosciences downgraded to Neutral from Buy at Chardan
FB Facebook
$181.47

-6.97 (-3.70%)

05/02/19
05/02/19
INITIATION
Target $65

Outperform
Wedbush bullish on Uber, initiates coverage with an Outperform
As previously reported, Wedbush analyst Ygal Arounian started coverage of Uber (UBER) with an Outperform and $65 price target. The analyst notes that the ridesharing industry has become one of the most transformational growth sectors of the global consumer market over the past five years, with Uber establishing itself as the clear number 1 player and paving a similar road to what Amazon (AMZN) did to transform retail/e-commerce and Facebook (FB) did for social media. The brand loyalty of Uber is hard to dispute as the company continues to attract drivers and consumers "illustrating an impressive formula" to go after a $5.7T opportunity globally on transportation, which swells to $7T-$8T when including third-party food delivery and freight/logistics, he contends.
05/01/19
BARD
05/01/19
NO CHANGE
Target $118
BARD
Outperform
PayPal expressed confidence in intermediate earnings targets, says Baird
After attending an investor gathering with PayPal (PYPL) management, Baird analyst Colin Sebastian said his key takeaways from the meeting were management's ongoing confidence in intermediate-term earnings growth targets and the early signs of progress on expanding its marketplace partnerships, including news that PayPal will be providing the infrastructure for Facebook's (FB) Marketplace payment offering. Additionally, Sebastian noted that the UK Competition and Markets Authority issued a preliminary ruling that it does not believe PayPal's acquisition of iZettle raises any competitive concerns, which he sees as a key milestone to getting the deal approved. Sebastian keeps an Outperform rating and $118 price target on PayPal shares.
04/30/19
JPMS
04/30/19
NO CHANGE
Target $1310
JPMS
Overweight
Alphabet sub-20% sales growth to bring share pressure, says JPMorgan
JPMorgan analyst Doug Anmuth expects Alphabet (GOOGL) shares to be under pressure in the near-term given the company's sub-20% revenue growth in Q1 and downward earnings revisions. The exact drivers of Alphabet's slowing sales are unclear, and frustration around the company's lack of transparency will only increase, Anmuth tells investors in a post-earnings research note. The analyst, however, points out that Alphabet has maintained 20%-plus growth for a very long time, off a large base. He maintains an Overweight rating on the stock with a $1,310 price target but prefers shares of Facebook (FB), Amazon.com (AMZN) and Netflix (NFLX) to Alphabet.
04/30/19
JMPS
04/30/19
NO CHANGE
Target $1300
JMPS
Outperform
Alphabet price target lowered to $1,300 from $1,375 at JMP Securities
JMP Securities analyst Ronald Josey said competition "may have played a role" in Alphabet's (GOOGL) worse than expected Q1 revenue given that better than expected advertising results have recently been reported by Facebook (FB), Twitter (TWTR), Snap (SNAP) and Amazon (AMZN). However, he believes the "majority of the deceleration was self-imposed," he tells investors in a post-earnings research note. Some of the company's product changes, such as changes at YouTube's recommendation engine, likely acted as a headwind, the analyst surmised. Josey sees benefits from investments in hardware and Google Cloud and thinks that multiple monetization opportunities remain for Alphabet, leading him to maintain an Outperform rating on the stock, though he lowered his price target on shares to $1,300 from $1,375.
TSN Tyson Foods
$79.59

-0.24 (-0.30%)

05/14/19
05/14/19
UPGRADE
Target $96

Outperform
Tyson Foods upgraded to Outperform at Credit Suisse
As previously reported, Credit Suisse analyst Robert Moskow upgraded Tyson Foods to Outperform from Neutral and raised his price target on the shares to $96 from $74. The analyst notes that consensus estimates already factor in stronger Chicken margins based on a rebound in the U.S. supply-demand cycle domestically. However, he does not think they fully account for the upside to chicken, beef, and pork prices from the outbreak of African Swine Fever.
05/14/19
ARGS
05/14/19
UPGRADE
ARGS
Buy
Tyson Foods upgraded to Buy from Hold at Argus
05/14/19
ARGS
05/14/19
UPGRADE
ARGS
Buy
Tyson Foods upgraded to Buy from Hold at Argus
Argus analyst John Staszak upgraded Tyson Foods to Buy with a price target of $92, also raising his FY19 EPS view by 10c to $6.20 and his FY20 target by 25c to $6.75. The analyst contends that the "growing demand for proteins" is positive for the company and other meat processors, with Tyson's beef division seeing an "especially strong demand". Staszak further cites the company's efforts to increase sales of prepared foods to meet the "steady demand and strong margins" while noting the 12.8-times forward earnings multiple on Tyson Foods stock, which is below the average large-cap food processor multiple of 18.4-times and in the lower half of its historical 9- to 19-times range.
05/14/19
FBCO
05/14/19
UPGRADE
FBCO
Outperform
Tyson Foods upgraded to Outperform from Neutral at Credit Suisse
ATHX Athersys
$1.58

-0.065 (-3.95%)

TRXC TransEnterix
$1.27

-0.02 (-1.55%)

11/09/18
LTCO
11/09/18
UPGRADE
Target $4.5
LTCO
Buy
TransEnterix upgraded to Buy from Neutral at Ladenburg
Ladenburg Thalmann analyst Jeffrey Cohen upgraded TransEnterix to Buy while lowering his price target for the shares to $4.50 from $6.
05/29/18
05/29/18
DOWNGRADE
Target $4

Neutral
TransEnterix downgraded to Neutral with $4 price target at Ladenburg
As previously reported, Ladenburg analyst Jeffrey Cohen downgraded TransEnterix to Neutral from Buy citing valuation with the stock having rallied after the company received FDA approval for expanded indications that now mean the Senhance system is approved for the most commonly performed surgeries in more than 95% of hospitals nationally. Cohen raised his price target for TransEnterix to $4 from $3.50.
05/14/19
BTIG
05/14/19
UPGRADE
Target $3
BTIG
Buy
TransEnterix upgraded to Buy from Neutral at BTIG
BTIG analyst Sean Lavin upgraded TransEnterix (TRXC) to Buy from Neutral with a $3 price target. The 40% pullback in the shares following the Q1 miss is overdone, Lavin tells investors in a research note. Individual issues at certain hospitals drove the shortfall, and there is a chance that next quarter and beyond could be better, says the analyst. He believes that while Intuitive Surgical (ISRG) using leasing to gain customers adds to TransEnterix's near-term risk, the shares offer more upside potential than downside risk at current prices.
06/28/18
BTIG
06/28/18
DOWNGRADE
BTIG
Neutral
TransEnterix downgraded to Neutral from Buy at BTIG
BTIG analyst Sean Lavin downgraded TransEnterix to Neutral citing the "rapid" rise in shares.
CYBR CyberArk
$121.06

-4.7 (-3.74%)

04/25/19
UBSW
04/25/19
DOWNGRADE
Target $132
UBSW
Neutral
CyberArk downgraded to Neutral from Buy at UBS
UBS analyst Fatima Boolani downgraded CyberArk to Neutral while also raising her price target to $132 from $119. The analyst says she remains bullish on the company's fundamentals as well as its execution consistency and "expanding mindshare in a market gone mainstream", which have accelerated the company's revenue growth to over 30% and supported the 70% year-to-date run-up in the stock price. Boolani notes however that CyberArk stock is now trading about 70% above its historical medians across her valuation metrics and sees its "big beats looking priced in".
03/26/19
MZHO
03/26/19
INITIATION
MZHO
Buy
CyberArk initiated with a Buy at Mizuho
Mizuho analyst Gregg Moskowitz initiated CyberArk with a Buy and $135 price target.
04/25/19
04/25/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Tesla (TSLA) downgraded to Neutral from Outperform at Wedbush with analyst Daniel Ives saying the demand story is quickly changing and the company has "unfortunately not adjusted to an evolving EV landscape." 2. PTC (PTC) downgraded to Underweight from Neutral at JPMorgan, to Underperform from Neutral at BofA/Merrill, and to Neutral on IoT/AR uncertainties at Wedbush. 3. Xilinx (XLNX) downgraded to Hold from Buy at Needham and to Neutral from Buy at Goldman Sachs. 4. Spirit Airlines (SAVE) downgraded to Neutral from Buy at BofA/Merrill with analyst Andrew Didora saying industry pricing has not improved and sees some cost pressures that limit upside potential. 5. CyberArk (CYBR) downgraded to Neutral from Buy at UBS with analyst Fatima Boolani saying she remains bullish on the company's fundamentals as well as its execution consistency and "expanding mindshare in a market gone mainstream," which have accelerated the company's revenue growth to over 30% and supported the 70% year-to-date run-up in the stock price. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/26/19
MZHO
03/26/19
INITIATION
MZHO
Mizuho initiates security software with top picks Palo Alto, CyberArk, Rapid7
Mizuho analyst Gregg Moskowitz initiated coverage of nine Security Software companies. In his industry update note, titled "Welcome to the New Age of Software - Part II," he noted that "macro concerns remain very prevalent and 4Q tech fundamentals were uneven," but added that he expects "security companies will navigate these issues well, due in part to the fact that cybersecurity consistently ranks at or near the top of IT spending priorities by CIOs." The analyst concluded that "while hardly immune, we would expect security spend to be relatively resilient." Moskowitz noted that global security revenue is currently well in excess of $40B, and growing at a roughly high-single digit CAGR. However, Moskowitz also noted that the security market is very fragmented and contains many sub-segments. He sees four security themes that he believes will become increasingly important, and should help to underpin healthy growth in the sector in the coming years -- Zero Trust, Identity Management, Next-gen Endpoint, and Machine Learning/Automation. The analyst expects to see "generally similar levels of security M&A activity in 2019," although he noted that one variable that could cause this to skew higher would be a large security vendor takeout, which is a historical rarity. Moskowitz initiated three stocks with Buy ratings -- Palo Alto Networks (PANW), CyberArk Software (CYBR), and Rapid7 (RPD) -- and six stocks with Neutral ratings -- Check Point Software (CHKP), FireEye (FEYE), Fortinet (FTNT), Okta (OKTA), Proofpoint (PFPT), and Symantec (SYMC).
ALLT Allot Communications
$7.28

-0.07 (-0.95%)

10/12/18
LEHM
10/12/18
UPGRADE
Target $6
LEHM
Equal Weight
Allot Communications upgraded to Equal Weight from Underweight at Barclays
Barclays analyst Joseph Wolf upgraded Allot Communications to Equal Weight and raised his price target for the shares to $6 from $5.
08/06/18
NEED
08/06/18
UPGRADE
Target $6.35
NEED
Buy
Allot Communications upgraded to Buy at Needham on profitability return in FY19
As noted earlier, Needham analyst Alex Henderson upgraded Allot Communications to Buy from Hold with a price target of $6.35, citing the results from the company's adjusted focus from Deep Packet Inspection, or DPI, technology to Service Provider Network Intelligence and Security. The analyst notes that he has "patiently" watched the transition, but now believes that the strategy has "taken hold", anticipating Allot to produce "double digit growth, improving margins and returning to profitability in 2019". Henderson adds that the company's recent wins are indicative of the strategy's progress.
08/06/18
NEED
08/06/18
UPGRADE
NEED
Buy
Allot Communications upgraded to Buy from Hold at Needham
RL Ralph Lauren
$118.28

-5.97 (-4.80%)

05/09/19
05/09/19
UPGRADE
Target $145

Outperform
Ralph Lauren upgraded to Outperform at RBC Capital on higher FY20 margin outlook
As previously reported, RBC Capital analyst Kate Fitzsimons upgraded Ralph Lauren to Outperform from Sector Perform and raised her price target to $145 from $135. The analyst cites the company's sales recovery exceeding expectations and anticipates continued progress in FY20. Despite the 20% year-to-date run-up in Ralph Lauren shares, Fitzsimons sees "another leg up" this year given the company's prospects for gross margin improvement and a "likely return to operating expense leverage."
05/09/19
RBCM
05/09/19
UPGRADE
RBCM
Outperform
Ralph Lauren upgraded to Outperform from Sector Perform at RBC Capital
05/14/19
COWN
05/14/19
NO CHANGE
COWN
Skechers, G-III among apparel names with outsized tariff risk, says Cowen
Cowen analyst John Kernan said 34% of apparel and about 70% of footwear imported into the U.S. come from China, adding that 25% tariffs on apparel and footwear will create "major disruption" at a time when companies are already facing accelerating disruption from technology and Amazon (AMZN). The analyst, who thinks diversifying from China sourcing will be slow, said he views Skechers (SKX), G-III Apparel (GIII), Carter's (CRI), PVH Corp. (PVH) and Ralph Lauren (RL) as among the apparel stocks with outsized EPS risk. He added that he thinks companies like Under Armour (UAA), that may have lower than sector average exposure to China sourcing but also have lower EBIT margins, as faced with greater sensitivity to higher cost of goods.
04/26/19
04/26/19
UPGRADE

Positive
Follow-up: Ralph Lauren upgraded to Positive from Mixed at OTR Global
As previously reported, OTR Global upgraded Ralph Lauren to Positive from Mixed. The firm's checks indicate Q4 wholesale orders improved in Western Europe, helped by more youthful, on-trend offerings and improved brand appeal. U.S. wholesale orders were up year-over-year and menswear buyers said the response to new merchandise was positive.
LMNR Limoneira
$21.99

-1 (-4.35%)

05/14/19
LSCM
05/14/19
NO CHANGE
Target $28
LSCM
Buy
Limoneira results hurt by rains in Southern California, says Lake Street
Poor weather hurt Limoneira's lemon and orange businesses in the company's preliminary Q2 results, Lake Street analyst Chris Krueger tells investors in a research note. While the company continues to execute on its global lemon strategy, heavy rains in Southern California caused volatility in its core business, which should normalize in the coming quarters, adds the analyst. He remains confident Limoneira will continue to grow its core agribusiness and generate additional cash flow from its real estate and water rights. Krueger lowered his price target for the shares to $28 from $31 and keeps a Buy rating on Limoneira.
09/11/18
LSCM
09/11/18
NO CHANGE
Target $31
LSCM
Buy
Limoneira shares will likely sell off today, says Lake Street
Lake Street analyst Chris Krueger expects shares of Limoneira to sell off today following last night's earnings shortfall on weather. The stock had risen 65% since February and was pricing in expectations of a Q3 beat and guidance increase, neither of which happened, Krueger tells investors in a post-earnings research note. While sales beat estimates, poor weather hurt margins and caused an earnings miss, the analyst explains. However, he remains confident Limoneira will continue to grow its core agribusiness and generate additional cash flow from its real estate and water rights. Krueger raised his price target for the shares to $31 from $30 and keeps Buy rating on the name.
01/08/19
SPHN
01/08/19
INITIATION
Target $24
SPHN
Overweight
Limoneira initiated with an Overweight at Stephens
Stephens analyst Ben Bienvenu initiated coverage of Limoneira with an Overweight rating and $24 price target, stating that it has a unique position and portfolio of assets along with a "compelling" long-term growth story. He sees Limoneira's earnings approaching an inflection point that he expects to begin in FY19, Bienvenu added.
05/14/19
SPHN
05/14/19
DOWNGRADE
Target $18
SPHN
Equal Weight
Limoneira downgraded to Equal Weight from Overweight at Stephens
Stephens analyst Ben Bienvenu downgraded Limoneira to Equal Weight from Overweight and lowered his price target for the shares to $18 from $25. While the company lowered its full year guidance, second half of 2019 expectations remain too aggressive to totally eliminate the risk of another guidance reduction later in the year, Bienvenu tells investors in a research note. The analyst expects Limoneira shares to trade off today given the magnitude of the Q2 miss and lack of visibility into the remainder of fiscal 2019.
TME Tencent Music
$16.00

-0.585 (-3.53%)

05/13/19
CHRS
05/13/19
INITIATION
CHRS
Hold
Tencent Music initiated with a Hold at China Renaissance
03/20/19
FBCO
03/20/19
DOWNGRADE
FBCO
Neutral
Tencent Music downgraded to Neutral from Outperform at Credit Suisse
Credit Suisse downgraded Tencent Music to Neutral from Outperform citing valuation.
02/12/19
02/12/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Viavi (VIAV) initiated with an Outperform at Northland. 2. CECO Environmental (CECE) initiated with a Buy at B. Riley FBR. 3. Tencent Music (TME) initiated with an Outperform at Macquarie. 4. Enable Midstream (ENBL) initiated with a Neutral at Mizuho. 5. Elanco (ELAN) initiated with a Market Perform at William Blair. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
02/12/19
MACQ
02/12/19
INITIATION
MACQ
Outperform
Tencent Music initiated with an Outperform at Macquarie

TODAY'S FREE FLY STORIES

SE

Sea Limited

$25.38

-0.42 (-1.63%)

19:04
05/21/19
05/21
19:04
05/21/19
19:04
Hot Stocks
Sea Limited reports Q1 QAUs up 114.4% from last year »

Reports Q1 Quarterly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

SE

Sea Limited

$25.38

-0.42 (-1.63%)

19:02
05/21/19
05/21
19:02
05/21/19
19:02
Earnings
Sea Limited reports Q1 EPS (64c), consensus (68c) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

SNE

Sony

$51.01

-1.195 (-2.29%)

18:48
05/21/19
05/21
18:48
05/21/19
18:48
Periodicals
Sony aims to bolster cash flow to better compete in chips, games, NAR says »

Sony is seeking to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jun

OOMA

Ooma

$14.49

-0.45 (-3.01%)

, CVI

CVR Energy

$47.29

0.9 (1.94%)

18:47
05/21/19
05/21
18:47
05/21/19
18:47
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: Ooma…

OOMA

Ooma

$14.49

-0.45 (-3.01%)

CVI

CVR Energy

$47.29

0.9 (1.94%)

PVH

PVH Corp.

$108.53

2.5075 (2.37%)

PSTG

Pure Storage

$20.60

0.6 (3.00%)

JWN

Nordstrom

$37.88

0.42 (1.12%)

URBN

Urban Outfitters

$27.01

0.05 (0.19%)

TOL

Toll Brothers

$38.34

0.82 (2.19%)

ONCS

OncoSec

$3.95

0.149 (3.92%)

EKSO

Ekso Bionics

$1.84

-0.06 (-3.16%)

TOCA

Tocagen

$8.81

-0.18 (-2.00%)

LIQT

LiqTech

$9.29

-0.21 (-2.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 21

    May

  • 21

    May

  • 21

    May

  • 22

    May

  • 23

    May

  • 28

    May

  • 29

    May

  • 30

    May

  • 30

    May

  • 03

    Jun

  • 04

    Jun

  • 05

    Jun

  • 06

    Jun

  • 10

    Jun

  • 20

    Jun

  • 20

    Jun

  • 20

    Jun

  • 09

    Jul

  • 22

    May

  • 22

    May

  • 22

    May

TREX

Trex Company

$61.44

2.38 (4.03%)

18:45
05/21/19
05/21
18:45
05/21/19
18:45
Hot Stocks
Trex Company CEO: There is no demand issue »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

CRMT

America's Car-Mart

$101.76

1.74 (1.74%)

18:34
05/21/19
05/21
18:34
05/21/19
18:34
Earnings
America's Car-Mart reports Q4 EPS $2.07, consensus $1.82 »

Reports Q4 revenue $177M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 30

    May

  • 13

    Nov

JCOM

j2 Global

$87.23

0.75 (0.87%)

18:25
05/21/19
05/21
18:25
05/21/19
18:25
Hot Stocks
j2 Global CFO sells 5.6K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 22

    May

  • 05

    Jun

NVS

Novartis

$82.38

0.36 (0.44%)

18:24
05/21/19
05/21
18:24
05/21/19
18:24
Hot Stocks
Novartis CEO: We are entering an exciting growth phase for the company »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 31

    May

EADSY

Airbus

$0.00

(0.00%)

18:20
05/21/19
05/21
18:20
05/21/19
18:20
Periodicals
Airbus in talks to find resolution to German arms export row, Reuters says »

Airbus CEO Guillaume…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGRO

Adecogro

$6.50

0.07 (1.09%)

18:19
05/21/19
05/21
18:19
05/21/19
18:19
Earnings
Adecogro reports Q1 adjusted EBITDA $58.3M, down 5.9% from last year »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,149.14

10.81 (0.95%)

, GOOGL

Alphabet Class A

$1,154.26

8.98 (0.78%)

18:01
05/21/19
05/21
18:01
05/21/19
18:01
Hot Stocks
Google updates policy on abortion-related ads »

Google said in a post…

GOOG

Alphabet

$1,149.14

10.81 (0.95%)

GOOGL

Alphabet Class A

$1,154.26

8.98 (0.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 19

    Jun

  • 27

    Oct

HAIN

Hain Celestial

$23.90

0.45 (1.92%)

17:50
05/21/19
05/21
17:50
05/21/19
17:50
Hot Stocks
Engaged Capital raises stake in Hain Celestial to 20.2% from 18.3% »

Engaged Capital raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTDOY

Nintendo

$0.00

(0.00%)

17:48
05/21/19
05/21
17:48
05/21/19
17:48
Hot Stocks
Nintendo to end 'Animal Crossing,' 'Fire Emblem' mobile game service in Belgium »

Nintendo announced that,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jun

  • 11

    Jun

URBN

Urban Outfitters

$27.01

0.05 (0.19%)

17:44
05/21/19
05/21
17:44
05/21/19
17:44
Hot Stocks
Urban Outfitters sees Q2 URBN retail SSS in low single-digit negative range »

Says guidance based on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 04

    Jun

GLD

SPDR Gold Shares

$120.34

-0.31 (-0.26%)

17:42
05/21/19
05/21
17:42
05/21/19
17:42
Hot Stocks
SPDR Gold Shares holdings rise to 739.69MT from 736.17MT »

This is the highest level…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASCMA

Ascent Capital

$0.91

0.0502 (5.87%)

17:38
05/21/19
05/21
17:38
05/21/19
17:38
Hot Stocks
Ascent Capital and Monitronics International announce restructuring support pact »

Ascent Capital Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRS

TriMas

$30.33

0.39 (1.30%)

17:33
05/21/19
05/21
17:33
05/21/19
17:33
Hot Stocks
TriMas VP Joshua Sherbin sells over $646K in company shares »

TriMas VP Joshua Sherbin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SUNW

Sunworks

$0.71

-0.1024 (-12.65%)

17:33
05/21/19
05/21
17:33
05/21/19
17:33
Syndicate
Breaking Syndicate news story on Sunworks »

Sunworks files $50M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LFUS

Littelfuse

$170.78

1.7 (1.01%)

, SMTC

Semtech

$44.74

0.36 (0.81%)

17:32
05/21/19
05/21
17:32
05/21/19
17:32
Initiation
Littelfuse, Semtech, CTS Corporation, Vishay initiated  »

Cowen initiates discrete…

LFUS

Littelfuse

$170.78

1.7 (1.01%)

SMTC

Semtech

$44.74

0.36 (0.81%)

CTS

CTS Corporation

$27.91

0.33 (1.20%)

VSH

Vishay

$16.43

0.37 (2.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 29

    May

  • 13

    Jun

  • 27

    Jun

GVA

Granite Construction

$41.46

0.5 (1.22%)

17:31
05/21/19
05/21
17:31
05/21/19
17:31
Hot Stocks
Granite Construction awarded $505M high speed rail contract »

Granite announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

OMC

Omnicom

$80.09

0.69 (0.87%)

17:30
05/21/19
05/21
17:30
05/21/19
17:30
Syndicate
Breaking Syndicate news story on Omnicom »

Omnicom files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TTEC

TTEC Holdings

$38.68

0.51 (1.34%)

17:26
05/21/19
05/21
17:26
05/21/19
17:26
Hot Stocks
TTEC Holdings EVP DeGhetto sells 35K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 10

    Jun

  • 11

    Jun

  • 12

    Jun

  • 16

    Jun

TDW

Tidewater

$24.80

0.31 (1.27%)

17:25
05/21/19
05/21
17:25
05/21/19
17:25
Hot Stocks
Tidewater director Dick Fagerstal purchases almost $107K shares of company stock »

Tidewater director Dick…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

PTCT

PTC Therapeutics

$40.07

2.67 (7.14%)

17:16
05/21/19
05/21
17:16
05/21/19
17:16
Hot Stocks
Point72 Asset Management takes 5.0% passive stake in PTC Therapeutics »

Point72 Asset Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 31

    May

  • 12

    Jun

DRIO

DarioHealth

$0.72

-0.0095 (-1.30%)

17:10
05/21/19
05/21
17:10
05/21/19
17:10
Syndicate
DarioHealth files to sell common stock, no amount given »

Craig-Hallum Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.